P & G Health Ltd

{
  "main_header": {
    "sid": 346859,
    "name": "P & G Health Ltd",
    "stock_name": "P & G Health Ltd",
    "full_name": "Procter & Gamble Health Ltd",
    "name_url": "stocks-analysis/p-g-health",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,670.05",
    "chg": 12.15,
    "chgp": "0.21%",
    "dir": 1,
    "prev_price": "5,657.90",
    "mcapval": "9,411.93 Cr",
    "mcap": "Small Cap",
    "scripcode": 500126,
    "symbol": "PGHL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE199A01012",
    "curr_date": "Sep 07, 03:14 PM",
    "curr_time": "15:15 PM",
    "last_traded_at": "Sep 07, 03:14 PM IST",
    "bse_nse_vol": "3.73 k",
    "exc_status": "Active",
    "traded_date": "Sep 07, 2026",
    "traded_date_str": "2026 09 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Procter & Gamble Health Ltd Downgraded to Sell Amid Technical and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-downgraded-to-sell-amid-technical-and-valuation-concerns-4184919",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ProcterGambleHe_mojoScore_4184919.png",
        "date": "2026-09-07 08:08:03",
        "description": "Procter & Gamble Health Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by deteriorating technical indicators and flat financial performance in the recent quarter. Despite a strong return over the long term, the company’s valuation and near-term trends have raised concerns among analysts, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Procter & Gamble Health Ltd Faces Technical Momentum Shift Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-faces-technical-momentum-shift-amid-market-challenges-4184543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ProcterGambleHe_technicaldot_4184543.png",
        "date": "2026-09-07 08:01:20",
        "description": "Procter & Gamble Health Ltd (P&G Health) has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of early September 2026. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively suggest a cautious outlook for investors amid a challenging market environment."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-hold-4170109",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ProcterGambleHe_mojoScore_4170109.png",
        "date": "2026-08-26 10:10:40",
        "description": "Procter & Gamble Health Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 3 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-amp-gamble-health-ltd-is-rated-hold-4155179",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ProcterGambleHe_mojoScore_4155179.png",
        "date": "2026-08-15 10:10:15",
        "description": "Procter & Gamble Health Ltd is rated Hold by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Procter & Gamble Health Ltd Falls 6.79%: Mixed Signals and Margin Pressures Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-falls-679-mixed-signals-and-margin-pressures-shape-the-week-4143850",
        "imagepath": "",
        "date": "2026-08-09 09:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Mojo Grade downgraded to Hold amid mixed technical and valuation signals</p>\n                    <p><strong>4 Aug:</strong> Technical momentum shifts to mildly bullish with mixed indicator readings</p>\n                    <p><strong>6 Aug:</strong> Intraday low hit at Rs.6,067.65 amid price pressure and volatility</p>\n                    <p><strong>7 Aug:</strong> Quarterly financial trend flattens despite strong PAT growth</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,597.45</div></div>\n                    <div class=\"stat-item\"><div..."
      },
      {
        "title": "Procter & Gamble Health Ltd Reports Flat Quarterly Financial Trend Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-reports-flat-quarterly-financial-trend-amid-margin-pressures-4140821",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ProcterGambleHe_fintrenddot_4140821.png",
        "date": "2026-08-07 08:00:12",
        "description": "Procter &amp; Gamble Health Ltd has experienced a notable shift in its financial trajectory during the quarter ended June 2026, with its financial trend moving from positive to flat. Despite this moderation, the company posted a robust earnings per share (EPS) of ₹57.92, marking its highest quarterly figure to date, while its profit after tax (PAT) for the last six months grew by an impressive 31.18% to ₹167.07 crores."
      },
      {
        "title": "Procter & Gamble Health Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-hits-intraday-low-amid-price-pressure-4140278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ProcterGambleHe_priceRelatedfactors_4140278.png",
        "date": "2026-08-06 15:31:20",
        "description": "Procter & Gamble Health Ltd experienced a notable decline today, touching an intraday low of Rs 6,067.65 as the stock faced significant price pressure. The pharmaceutical and biotechnology company underperformed its sector and broader market indices, continuing a downward trend over the past several sessions."
      },
      {
        "title": "Procter & Gamble Health Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4135758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ProcterGambleHe_mojoScore_4135758.png",
        "date": "2026-08-04 08:26:55",
        "description": "Procter & Gamble Health Ltd (P&G Health) has seen its investment rating downgraded from Buy to Hold as of 3 August 2026, reflecting a nuanced shift in its technical outlook, valuation metrics, financial trends, and overall quality assessment. Despite strong quarterly financials and robust management efficiency, the stock’s technical indicators and valuation multiples have prompted a more cautious stance among analysts."
      },
      {
        "title": "Procter & Gamble Health Ltd Sees Technical Momentum Shift Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-sees-technical-momentum-shift-amid-mixed-signals-4134483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ProcterGambleHe_technicaldot_4134483.png",
        "date": "2026-08-04 08:03:06",
        "description": "Procter &amp; Gamble Health Ltd, a small-cap player in the Pharmaceuticals &amp; Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 1.62%, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the latest technical parameters, price momentum, and relative performance against the Sensex to provide a comprehensive view for investors."
      }
    ],
    "total": 199,
    "sid": "346859",
    "stock_news_url": "https://www.marketsmojo.com/news/procter-gamble-health-346859"
  },
  "announcements": [
    {
      "caption": "Re-Appointment Of Mr. S. Madhavan As Independent Director Of The Company.",
      "datetime": "04-Sep-2026",
      "details": "The shareholders at their AGM held on September 3 2026 approved the re-appointment of Mr. S. Madhavan as Independent Director of the Company for a period of 5 years effective November 15 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "04-Sep-2026",
      "details": "Scrutinizers Report and E-Voting results for the Annual General Meeting held on September 3 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "03-Sep-2026",
      "details": "Enclosed a summary of proceedings of the Annual General Meeting held today viz. September 3 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Procter & Gamble Health Ltd has declared <strong>450%</strong> dividend, ex-date: 27 Aug 26",
          "dt": "2026-08-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Procter & Gamble Health Ltd Downgraded to Sell Amid Technical and Valuation Concerns

2026-09-07 08:08:03

Procter & Gamble Health Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by deteriorating technical indicators and flat financial performance in the recent quarter. Despite a strong return over the long term, the company’s valuation and near-term trends have raised concerns among analysts, prompting a reassessment of its investment appeal.

Read full news article

Procter & Gamble Health Ltd Faces Technical Momentum Shift Amid Market Challenges

2026-09-07 08:01:20

Procter & Gamble Health Ltd (P&G Health) has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of early September 2026. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively suggest a cautious outlook for investors amid a challenging market environment.

Read full news article

Procter & Gamble Health Ltd is Rated Hold

2026-08-26 10:10:40

Procter & Gamble Health Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 3 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 26 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Procter & Gamble Health Ltd is Rated Hold

2026-08-15 10:10:15

Procter & Gamble Health Ltd is rated Hold by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Procter & Gamble Health Ltd Falls 6.79%: Mixed Signals and Margin Pressures Shape the Week

2026-08-09 09:00:06

Key Events This Week

3 Aug: Mojo Grade downgraded to Hold amid mixed technical and valuation signals

4 Aug: Technical momentum shifts to mildly bullish with mixed indicator readings

6 Aug: Intraday low hit at Rs.6,067.65 amid price pressure and volatility

7 Aug: Quarterly financial trend flattens despite strong PAT growth

Week Open

Rs.6,597.45

Read full news article

Procter & Gamble Health Ltd Reports Flat Quarterly Financial Trend Amid Margin Pressures

2026-08-07 08:00:12

Procter & Gamble Health Ltd has experienced a notable shift in its financial trajectory during the quarter ended June 2026, with its financial trend moving from positive to flat. Despite this moderation, the company posted a robust earnings per share (EPS) of ₹57.92, marking its highest quarterly figure to date, while its profit after tax (PAT) for the last six months grew by an impressive 31.18% to ₹167.07 crores.

Read full news article

Procter & Gamble Health Ltd Hits Intraday Low Amid Price Pressure

2026-08-06 15:31:20

Procter & Gamble Health Ltd experienced a notable decline today, touching an intraday low of Rs 6,067.65 as the stock faced significant price pressure. The pharmaceutical and biotechnology company underperformed its sector and broader market indices, continuing a downward trend over the past several sessions.

Read full news article

Procter & Gamble Health Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-08-04 08:26:55

Procter & Gamble Health Ltd (P&G Health) has seen its investment rating downgraded from Buy to Hold as of 3 August 2026, reflecting a nuanced shift in its technical outlook, valuation metrics, financial trends, and overall quality assessment. Despite strong quarterly financials and robust management efficiency, the stock’s technical indicators and valuation multiples have prompted a more cautious stance among analysts.

Read full news article

Procter & Gamble Health Ltd Sees Technical Momentum Shift Amid Mixed Signals

2026-08-04 08:03:06

Procter & Gamble Health Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 1.62%, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the latest technical parameters, price momentum, and relative performance against the Sensex to provide a comprehensive view for investors.

Read full news article

View All News